Related by context. All words. (Click for frequent words.) 66 cachexia 65 ostarine 65 INCB# [001] 65 Tasimelteon 65 Cancer Cachexia 65 SHPT 64 selective androgen receptor modulator 64 Xanafide 64 diabetic neuropathic pain 64 non alcoholic steatohepatitis 64 myeloproliferative neoplasms 64 diarrhea predominant irritable 64 CTAP# Capsules 64 secondary hyperparathyroidism 63 ACV1 63 lomitapide 63 OHR/AVR# 63 lupus nephritis 63 Squalamine 63 myeloproliferative disorders 63 TELINTRA 63 velafermin 63 SARMs 63 refractory gout 63 dopaminergic therapy 62 terlipressin 62 myelofibrosis polycythemia vera 62 RNAi therapeutic targeting 62 CYT# potent vascular disrupting 62 inhibitor RG# 62 Familial Adenomatous Polyposis FAP 62 carcinoid syndrome 62 YONDELIS 62 leukemia AML 62 rhIGF-I/rhIGFBP-3 62 nucleoside analog 62 Fabry Disease 62 Severe Primary IGFD 62 prokinetic agent 62 oral prodrug 62 post herpetic neuralgia PHN 62 Cachexia 62 postoperative ileus 62 schizophrenia CIAS 62 octreotide implant 62 kidney urologic 61 Interferon alpha 61 beta 1a 61 Cancer cachexia 61 AA Amyloidosis 61 Mipomersen 61 Fibrillex TM 61 atypical hemolytic uremic syndrome 61 ThGRF 61 Laquinimod 61 Critical Limb Ischemia CLI 61 efalizumab 61 erlotinib Tarceva ® 61 albiglutide 61 MELAS 61 hyperphenylalaninemia HPA due 61 selective modulator 61 alvespimycin 61 TNF Tumor Necrosis Factor 61 Xyfid TM 61 Myelodysplastic Syndrome MDS 61 chronic eosinophilic leukemia 61 skeletal muscle weakness 61 PRTX 61 AA amyloidosis 61 ISIS # 61 potassium sparing diuretics 61 INCB# [003] 61 benign prostatic hypertrophy BPH 61 cell lymphoma CTCL 61 novel VDA molecule 61 Primary IGFD 61 psoriasis rheumatoid arthritis 61 growth hormone secretion 61 EVIZON TM 61 NAGS deficiency 61 progressive neurodegenerative disorder 61 Aviptadil 61 thetreatment 61 PXD# 61 forodesine 61 Symadex 61 sorafenib tablets 61 complement inhibitor eculizumab 61 nonalcoholic steatohepatitis 61 hyperphosphatemia 61 postoperative ileus POI 61 hematologic disorders 61 elevated triglyceride levels 61 dyskinesia PD LID 61 uricase 61 C1 INH 61 treat hyperphosphatemia 61 recurrent glioblastoma multiforme 61 Phenoptin 61 Vandetanib 61 Factor VIIa 61 visilizumab 61 vidofludimus 61 investigational therapies 60 chronic renal disease 60 R Saizen R 60 Triolex 60 TTR amyloidosis 60 hypoparathyroidism 60 psoriasis psoriatic arthritis 60 rheumatoid arthritis multiple sclerosis 60 Eculizumab 60 hypercholesterolemia 60 chronic thromboembolic pulmonary 60 CEQ# 60 R#/MEM # 60 mGluR2 NAM 60 Leber Hereditary Optic Neuropathy 60 Immunotherapeutic 60 Hepatocellular Carcinoma HCC 60 Golimumab 60 IL# PE#QQR 60 Microplasmin 60 levodopa carbidopa 60 orally administered inhibitor 60 renal toxicity 60 Acute Radiation Syndrome ARS 60 HGS# 60 JAK2 inhibitor 60 pan HDAC inhibitor 60 gamma secretase inhibitor 60 sodium thiosulfate STS 60 GRNCM1 60 diabetic nephropathy 60 gefitinib Iressa 60 severe gastroparesis 60 gastrointestinal mucositis 60 pulmonary arterial hypertension PAH 60 cMET 60 VEGF inhibitors 60 imatinib Gleevec ® 60 mixed hyperlipidemia 60 debilitating autoimmune 60 teduglutide 60 familial amyloidotic polyneuropathy FAP 60 SNT MC# 60 mixed dyslipidemia 60 Non Alcoholic Steatohepatitis 60 AEG# 60 dimebon 60 sJIA 60 Rheumatoid Arthritis RA 60 fibrotic disease 60 metastatic castration resistant 60 davunetide intranasal AL 60 hematological malignancy 60 Telintra 60 PD LID 60 Vidaza azacitidine 60 FOLOTYN ® 60 TACI Ig 60 Cushing Syndrome 60 Myelodysplastic syndromes MDS 60 IAP inhibitor 60 SGS# 60 constipation OIC 60 AGILECT R 60 lumiliximab 60 pathophysiological effects 60 acadesine 60 Lupus Nephritis 60 Bronchiectasis 60 Syncria R 60 overt nephropathy 60 Personalized Immunotherapy 60 riociguat 60 serum phosphate 60 Pseudomonas aeruginosa infections 60 Corlux 60 PAOD 60 PSN# [002] 60 antibody MAb 60 ALN TTR 60 systemic lupus erythematosus 60 dexpramipexole 60 formerly LymphoStat B 60 sunitinib malate 60 insulin sensitizing 59 Inhalation Solution 59 Enzyme Replacement Therapy 59 hyperplasia BPH 59 Archexin 59 pramlintide 59 DDP# 59 RhuDex 59 serum phosphorous 59 Aflibercept 59 tuberous sclerosis TS 59 alemtuzumab treated 59 chronic myeloid 59 relapsed MM 59 hyperuricemia 59 Eltrombopag 59 disease GERD 59 Ceflatonin R 59 squalamine 59 Myelofibrosis 59 dasatinib Sprycel ® 59 tramiprosate 59 Pioglitazone 59 esophageal candidiasis 59 Traficet EN 59 metastatic GIST 59 erythropoietic 59 pouchitis 59 Decitabine 59 alpha interferons 59 Mucositis 59 diabetic gastroparesis 59 diabetic macular edema DME 59 primary hypercholesterolemia 59 Cloretazine 59 peritumoral brain edema 59 purpura ITP 59 EGFR inhibitors 59 efaproxiral 59 essential thrombocythemia 59 K ras mutations 59 Lung transplantation 59 ELND# 59 Tolvaptan 59 progressive neurodegenerative 59 ataluren 59 Granulocyte Colony Stimulating Factor 59 tiapamil 59 A1PI 59 rFIXFc 59 zanolimumab 59 dyslipidemia 59 hypereosinophilic syndrome 59 tafamidis 59 immuno inflammatory diseases 59 HuLuc# 59 rasagiline tablets 59 chronic idiopathic thrombocytopenic purpura 59 6R BH4 59 diabetes mellitus T2DM 59 relapsed leukemia 59 pulmonary hypertension PH 59 selective androgen receptor modulators 59 tanespimycin 59 therapeutic regimens 59 RhuDex R 59 MYCAMINE 59 lipid abnormalities 59 systemic juvenile idiopathic 59 endometrial hyperplasia 59 dirucotide MBP# 59 RhuDex TM 59 Safinamide 59 gastrointestinal GI motility disorders 59 Friedreich Ataxia FRDA 59 Bronchitol 59 EVIZON TM squalamine lactate 59 chorea associated 59 transthyretin TTR mediated amyloidosis 59 Proquin XR 59 Dasatinib 59 CTAP# 59 idiopathic thrombocytopenic purpura ITP 59 alemtuzumab Campath 59 Cinquil 59 Vidofludimus 59 HuMax CD4 59 HeFH 59 alvimopan 59 IBS C 59 IPL# 59 receptor tyrosine kinase inhibitor 59 favorable pharmacokinetic profile 59 fibromyalgia syndrome 59 nephropathic cystinosis cystinosis 59 opioid induced constipation 59 lupus erythematosus 59 ruboxistaurin 59 nephropathic cystinosis 59 hypercholesterolaemia 59 diabetic microvascular complications 59 VAPRISOL 59 symptomatic benign prostatic 59 ACTEMRA TM 59 hypophosphatasia 59 mertansine 59 pancreatic insufficiency 59 erythematosus 59 cirrhosis liver failure 59 Ribavirin causes 59 Serostim ® 59 systolic hypertension 59 Dacogen injection 59 ara C 59 immuno modulatory 59 Omacetaxine 59 relapsed multiple myeloma 59 Namenda ® 59 muscular dystrophy cystic fibrosis 59 hepatic encephalopathy 59 BENLYSTA TM 59 Ceflatonin 59 immunosuppressive therapies 59 pyridostigmine 59 skeletal muscle mass 59 lipid disorders 59 ALN PCS 59 cicletanine 59 pulmonary arterial hypertension 59 JAK inhibitor 59 INSPIRE Trial Phase III 59 Cleviprex TM clevidipine 59 aMCI precursor 59 Chronic lymphocytic leukemia 59 torsade de pointes 59 Parkinson disease levodopa induced 58 MIRAPEX ER 58 Bortezomib 58 Fx #A 58 SNT-MC#/idebenone 58 mTOR inhibitors 58 placebo controlled clinical 58 eosinophilic asthma 58 gastrointestinal disorders ATI 58 JAK inhibitors 58 Navelbine 58 bexarotene 58 bowel dysfunction 58 either acutely decompensated 58 cardio renal 58 essential thrombocythemia ET 58 LymphoStat B belimumab 58 iGVHD 58 MTP inhibitor 58 Natalizumab 58 cytopenias 58 evaluating tivozanib 58 endothelin receptor antagonists 58 T#I [002] 58 Darusentan 58 lapatinib Tykerb 58 Ocrelizumab 58 hematologic malignancies 58 ABCB1 58 HBeAg negative 58 Cimzia TM 58 myeloproliferative diseases 58 hyperprolactinemia 58 DITPA 58 oxypurinol 58 Pimavanserin 58 PNP inhibitor 58 polycythemia vera essential thrombocythemia 58 aclidinium bromide 58 LY# [003] 58 Mild Cognitive Impairment 58 Gleevec resistant 58 Plicera 58 Etanercept 58 diabetic retinopathy DR 58 Cloretazine R VNP#M 58 TYZEKA 58 Disease IBD 58 relapsed ALL 58 neurogenic orthostatic hypotension 58 lucinactant 58 Virulizin ® 58 safinamide 58 Dalbavancin 58 Tavocept 58 opioid induced bowel dysfunction 58 metastatic bone 58 muscular dystrophies 58 laquinimod 58 metastatic neuroendocrine tumors 58 sorafenib Nexavar 58 Muraglitazar 58 PEGylated interferon beta 1a 58 tezampanel 58 hepatorenal syndrome 58 chemotherapy induced neutropenia 58 sargramostim 58 phosphate binders 58 gastrointestinal stromal tumor GIST 58 myelodysplastic syndrome MDS 58 panitumumab Vectibix 58 proliferative diabetic retinopathy 58 relapsing remitting MS RRMS 58 Annamycin 58 MEK inhibitors 58 PKU genetic 58 Overactive bladder 58 cutaneous T 58 Azacitidine 58 Milnacipran 58 immunomodulatory effects 58 intermittent claudication 58 Lixivaptan 58 cannabinor 58 systemic lupus erythematosus psoriasis 58 pain palliation 58 Parkinson disease PD 58 Lenocta 58 systemic fungal infections 58 Alzhemed TM 58 dirucotide 58 HQK 58 T2DM 58 pegylated interferons 58 Nonalcoholic Steatohepatitis 58 thalidomide Thalomid 58 Cannabinor 58 neovascular diseases 58 calcineurin inhibitors 58 imatinib Gleevec 58 arthritis PsA 58 systemic mastocytosis 58 Guanilib 58 homozygous familial hypercholesterolemia 58 oral FTY# 58 Fludarabine 58 hypercalcemia 58 SYN# 58 Chronic Myeloid Leukemia 58 plasminogen activators 58 idiopathic thrombocytopenic purpura 58 SRT# [003] 58 chronic myocardial ischemia 58 neuroendocrine cancers 58 pediatric malignancies 58 CDP# 58 DPP4 inhibitor 58 Enzastaurin 58 ATACAND 58 vWD 58 aldehyde dehydrogenase ALDH2 deficiency 58 catheter occlusion 58 acute humoral rejection 58 Fenretinide 58 nonalcoholic steatohepatitis NASH 58 Aclidinium 58 HIV HCV coinfected 58 post menopausal osteoporosis 58 atypical Hemolytic Uremic Syndrome 58 NNRTIs 58 DFMO 58 aromatase inhibitors AIs 58 epithelial tumors 58 orthostatic hypotension 58 Maroteaux Lamy syndrome 58 extrapyramidal symptoms 58 Morquio 58 insulin sensitizers 58 Topiramate 58 RhuDex ™ 58 polymerase inhibitor 58 Alequel 58 cangrelor 58 immunomodulatory therapy 58 AVONEX ® 58 acute GvHD 58 lysosomal storage diseases 58 Trandolapril 58 dexanabinol 58 RhuDex ® 58 hepatitis C HCV 58 Iloperidone 58 painful diabetic neuropathy 58 PREOS 58 nucleotide analog 58 lipohypertrophy 58 palifermin 58 GATTEX TM 58 CD# CEA 58 fenretinide 58 lipid lowering therapies 58 Interferon beta 58 relapsed ovarian cancer 58 neovascular 58 eprotirome 58 alpha interferon 58 AGHD 58 autosomal dominant polycystic kidney 58 debilitating complication 58 Icatibant 58 Liprotamase 58 overactive bladder OAB 58 Leukemias 58 multiple myeloma MM 58 PKC# 58 neuropsychiatric symptoms 58 Pyridorin 58 vitreoretinal disorders 58 Hypertriglyceridemia 58 baminercept 58 Investigational Treatment 58 Voreloxin 58 pancreatic neuroendocrine tumors 58 metastatic malignant 58 bardoxolone methyl 58 ophthalmological diseases 58 posaconazole 58 Neovascular Age Related Macular 58 ATTR 58 acromegalic patients 58 SILENOR TM 58 diabetic kidney 58 R#/MEM 58 corticosteroid dexamethasone 58 Rotigotine 58 depsipeptide 58 OMNARIS HFA 58 gastrointestinal disorders characterized 58 dasatinib Sprycel 58 CDK inhibitor 58 histone deacetylase HDAC inhibitor 58 Cloretazine R 58 Zileuton 58 Alemtuzumab 57 vasomotor symptoms 57 ocular disorders 57 interferon IFN 57 Neovascular 57 Toxicities 57 Candesartan 57 Bicifadine 57 Cysteamine 57 Zometa zoledronic acid 57 vivo validation 57 CORT # 57 Rasagiline 57 Velcade bortezomib 57 Diabetic Macular Edema DME 57 mapatumumab 57 Alessandro Riva 57 TNF antagonist 57 Fibromyalgia Syndrome FMS 57 mGluR2 positive 57 smoldering myeloma 57 Avanafil 57 Vorinostat 57 chronic opioid 57 cytomegalovirus CMV 57 RAPAFLO R 57 Panzem R 57 DMARDS 57 anthracycline chemotherapy 57 hereditary emphysema 57 leukemia CLL 57 herpetic keratitis 57 claudication 57 inflammatory bowel diseases 57 small molecule defensin 57 refractory chronic lymphocytic 57 ORENCIA R 57 myelofibrosis MF 57 exocrine pancreatic insufficiency 57 SUTENT 57 deacetylase inhibitors 57 Navelbine ® 57 plasma kallikrein 57 myelodysplastic syndromes 57 phase IIa clinical 57 Rebif ® 57 delta gamma agonist 57 arterial thrombosis 57 virally induced 57 Tumor Necrosis Factor 57 axitinib 57 Cetrorelix 57 pertuzumab 57 GW# [003] 57 calcineurin inhibitor 57 Actemra tocilizumab 57 CRVO 57 Egrifta 57 induced macular edema 57 Nilotinib 57 trastuzumab Herceptin ® 57 ATL# [001] 57 Opioid induced 57 renal flares 57 mTOR mammalian target 57 Idiopathic Pulmonary Fibrosis 57 BAY #-# 57 LHRH antagonists 57 Diabetic nephropathy 57 Kamada AAT 57 pseudobulbar affect PBA 57 Torisel 57 hypercalcaemia 57 cause cardiac channelopathies 57 AAT deficiency 57 constipation predominant irritable bowel 57 receptor inhibitor 57 androgen independent 57 advanced hepatocellular carcinoma 57 Bucindolol 57 Non Alcoholic Fatty 57 Pirfenidone 57 Lubiprostone 57 opioid bowel dysfunction 57 Peripheral Artery Disease 57 interferon alfa 57 Remicade infliximab 57 transthyretin amyloidosis 57 HIV associated lipodystrophy 57 proliferator activated receptor 57 VEGF Trap 57 disease NAFLD 57 inflammatory autoimmune diseases 57 exocrine pancreatic insufficiency EPI 57 MP4OX 57 diabetic macular edema 57 Myelodysplastic Syndrome 57 Pulmonary hypertension 57 TRISENOX 57 conventional DMARDs 57 ADHF 57 Evoltra ® 57 HoFH 57 immunological diseases 57 Hypotension 57 lysosomal storage disease 57 HRPC 57 TRIOLEX HE# APOPTONE HE# 57 Magnesium deficiency 57 hour bronchodilation 57 myelodysplastic syndromes MDS 57 alefacept 57 TPMT 57 tizanidine hydrochloride short 57 proteasome inhibitor 57 Cutaneous T 57 GvHD 57 candidiasis 57 TRIOLEX 57 2 inhibitor CYT# 57 teplizumab 57 CIMZIA ™ 57 IGIV 57 Carcinoid tumors 57 Saxagliptin 57 lanreotide 57 AZILECT ® 57 cilengitide 57 cystinosis patients 57 INCB# [002] 57 targeted radiotherapeutic 57 Neulasta ® 57 Fingolimod 57 BENLYSTA ® 57 Pulmonary Arterial Hypertension 57 ATL/TV# 57 NASH Huntington 57 decitabine 57 HCV protease inhibitors 57 NSAID induced GI 57 YONDELIS R 57 bosentan 57 Entereg TM 57 Solazed TM 57 FASLODEX 57 gastro intestinal inflammation 57 treat lupus renal 57 GI motility disorders 57 abiraterone acetate 57 metastatic gastric 57 Degarelix 57 Dapagliflozin 57 Orally administered 57 Crohn disease CD 57 Allergic Rhinitis 57 adalimumab Humira 57 Duchenne muscular dystrophy DMD 57 investigational monoclonal antibody 57 azacitidine 57 Cancidas 57 Kepivance 57 CIMZIA TM certolizumab pegol 57 anti CD3 antibody 57 Vaprisol 57 acetonide FA 57 chronic HCV infection 57 galiximab 57 azoles 57 Esophagitis 57 Tiotropium 57 samarium Sm 57 BCR ABL inhibitor 57 Idiopathic Pulmonary Fibrosis IPF 57 steroid refractory ulcerative 57 Dupuytren Disease 57 Dosa suffers 57 solid organ transplantation 57 ELACYT 57 Romiplostim 57 CA4P 57 developing Bicifadine serotonin 57 MAXY VII 57 knee osteoarthritis OA 57 herpes zoster shingles 57 Entereg R 57 phase IIb clinical 57 refractory angina 57 Nocturia 57 cSSSI 57 colorectal carcinoma 57 candesartan cilexetil 57 immunodeficiency disorders 57 Acute Coronary Syndromes ACS 57 Panzem 57 tyrosine kinase inhibitor 57 AZILECT R 57 rheumatoid arthritis osteoarthritis ankylosing 57 HuMax EGFr 57 osteoarthritis rheumatoid arthritis 57 Acute Bacterial Sinusitis ABS 57 LHON 57 rheumatoid arthritis psoriatic arthritis 57 Lenalidomide 57 Amigal 57 hyperammonemia 57 mRCC 57 myelodysplastic myeloproliferative diseases 57 dextromethorphan quinidine 57 EndoTAG TM -1 57 Troxatyl 57 dexrazoxane 57 cystic fibrosis chronic pancreatitis 57 Mitoxantrone 57 AML MDS 57 Dacogen decitabine 57 uremic pruritus 57 TNF alpha antagonist 57 Zollinger Ellison Syndrome 57 MGd 57 Lymphocytic 57 Age Related Macular 57 CTEPH 57 Gabapentin GR 57 Enbrel Humira 57 atacicept 57 QTc prolongation 57 calcitonin 57 FRDA 57 AOD# [002] 57 Fc fusion protein 57 agomelatine 57 Tocilizumab 57 idursulfase 57 Initiates Clinical Trial 57 salmeterol inhalation powder 57 BCG refractory carcinoma 57 demonstrated antitumor activity 57 PROCRIT ® 56 selective inhibition 56 immunomodulatory 56 CellCept mycophenolate mofetil 56 Haptoglobin 56 ATTR CM 56 fluvastatin 56 recurrent glioblastoma 56 inhaled liposomal ciprofloxacin 56 anti amnesic 56 Ceflatonin ® 56 reslizumab 56 hypovitaminosis D 56 hypertriglyceridemia 56 haematological malignancies 56 nosocomial pneumonia 56 tocilizumab 56 Idiopathic pulmonary fibrosis 56 AAT Deficiency 56 idiopathic pulmonary fibrosis IPF 56 gastrointestinal motility 56 systemic autoimmune 56 acute mania 56 insulin resistance syndrome 56 octreotide 56 elotuzumab 56 synthetic retinoid 56 retinal dystrophies 56 MEK inhibitor 56 proliferative disorders 56 lenalidomide Revlimid R 56 Central Retinal Vein 56 Anti VEGF 56 secondary hyperparathyroidism SHPT 56 methylnaltrexone 56 Denufosol 56 Gastroparesis 56 Autoimmune diseases 56 metaglidasen 56 STRIDE PD 56 #beta HSD1 56 Campath alemtuzumab 56 dihydrochloride 56 Syndrome RLS 56 SGLT2 56 ocrelizumab 56 miglustat 56 octreotide LAR 56 prostate cancer AIPC 56 pharmacological chaperone 56 Nexavar sorafenib 56 CCX# 56 Atypical Hemolytic Uremic Syndrome 56 Amrubicin 56 glufosfamide 56 Arcalyst 56 MEK inhibitor RDEA# 56 hepatocellular carcinoma 56 neuro degenerative diseases 56 FAMPYRA 56 PsA 56 sitaxsentan 56 Prodarsan R 56 Asentar 56 EGFR tyrosine kinase inhibitors 56 Triapine 56 fibrotic diseases 56 pharmacokinetic interactions 56 AT1R 56 PDE4 inhibitor 56 pemphigus vulgaris 56 Chronic Lymphocytic Leukemia CLL 56 denileukin diftitox 56 hereditary antithrombin deficiency 56 Friedreich Ataxia 56 castrate resistant prostate cancer 56 JAK3 56 OncoVEX GM CSF 56 CCR9 antagonist 56 relapsed SCLC 56 heterozygous FH 56 lipid lowering agents 56 anticholinergic 56 HMG CoA reductase inhibitors 56 autoantibody positive 56 BCR ABL inhibitors 56 late onset Pompe 56 Lupus nephritis 56 dosing frequency 56 Zolinza 56 renin inhibitors 56 macroalbuminuria 56 renal fibrosis 56 immune modulator 56 sunitinib Sutent 56 chronic granulomatous disease 56 tumor lysis syndrome 56 vinca alkaloid 56 prostanoid 56 Miraxion 56 prucalopride 56 short bowel syndrome 56 Chronic Fatigue Syndrome CFS 56 amnestic mild cognitive impairment 56 APOPTONE 56 severe malignant osteopetrosis 56 Onglyza saxagliptin 56 JAK2 enzyme 56 temsirolimus 56 overactive bladder symptoms 56 systemic lupus erythematosus SLE 56 Pulmonary arterial hypertension 56 SAR# [002] 56 antiangiogenic therapy 56 induce remission 56 anticancer therapy 56 primary dysmenorrhea 56 G6PD deficiency 56 enzastaurin 56 angiotensin receptor blockers ARBs 56 metabolic acidosis 56 Teriparatide 56 hematological cancers 56 chronic renal failure 56 relapsing remitting multiple sclerosis 56 dyslipidaemia 56 Host Disease GvHD 56 engineered RAP peptides 56 Eisenmenger syndrome 56 reperfusion injury 56 polyneuropathy CIDP 56 Silodosin 56 Daclizumab 56 primary Restless Legs 56 juvenile idiopathic arthritis 56 nausea vomiting headache 56 Sezary syndrome 56 beta interferons 56 GAMMAGARD LIQUID 56 Pathway Inhibitor 56 Tamibarotene 56 Preclinical studies suggest 56 GAMMAGARD 56 Sudhir Agrawal D.Phil 56 sPLA2 56 Polyneuropathy 56 AKT inhibitor 56 NovaBay Aganocide compounds 56 glatiramer acetate 56 sarcopenia 56 Exelixis XL# 56 neuronal dysfunction 56 symptomatic neurogenic orthostatic hypotension 56 Glioblastoma Multiforme 56 Benign Prostatic Hyperplasia BPH 56 impaired cognition 56 Aryplase 56 paroxysmal nocturnal hemoglobinuria 56 familial hypercholesterolemia 56 degenerative disorders 56 Hp2 2 56 prostate cancer CaP 56 LHRH agonists 56 romazarit 56 Detrol Detrol LA 56 tumors GIST 56 non metastatic osteosarcoma 56 RNAi therapeutic targeting PCSK9 56 tetrabenazine 56 neuropathic pain spasticity 56 noninfectious uveitis 56 Tramiprosate ALZHEMED TM 56 hereditary degenerative 56 malignant pleural mesothelioma 56 Alzheimer Disease Cooperative 56 levodopa therapy 56 UPLYSO 56 bronchodilatory 56 SPRYCEL ® 56 Diabetic Macular Edema 56 Ranolazine 56 post herpetic neuralgia 56 SUTENT ® 56 daclizumab 56 MPS VI 56 ankylosing spondylitis AS 56 familial hypercholesterolemia FH 56 Virulizin R 56 galantamine 56 pulmonary exacerbations 56 anti angiogenic agents 56 Noxafil 56 dextofisopam 56 myelofibrosis 56 Dupuytren Contracture 56 antibody mediated rejection 56 hypothalamic amenorrhea 56 mu opioid receptor antagonist 56 diabetic peripheral neuropathy DPN 56 BARACLUDE ® 56 rheumatoid arthritis Crohn disease 56 monoclonal antibody MAb 56 sodium glucose cotransporter 56 LHRH receptor positive 56 trospium 56 Tarceva erlotinib 56 nalbuphine ER 56 Bezielle 56 subependymal giant cell 56 epilepsy Parkinson disease 56 GRNOPC1 contains 56 nonmelanoma skin cancers 56 RAPTIVA 56 hematological malignancies 56 APTIVUS r 56 Prodarsan ® 56 nitazoxanide 56 transplantation HCT 56 glitazones 56 hematopoietic cell 56 Psoriatic arthritis 56 Acute Myeloid Leukemia 56 Myelodysplastic Syndromes 56 lung fibrosis 56 Systemic lupus erythematosus SLE 56 relapsing multiple sclerosis 56 Sutent sunitinib 56 Microalbuminuria 56 tasimelteon 56 pomalidomide 56 severe oral mucositis 56 endothelin antagonist 56 antidiabetic drugs 56 rheumatoid arthritis juvenile idiopathic 56 Zenapax 56 Rebif interferon beta 1a